P. Diamantopoulos

M. Angelopoulou, J. Barbetseas, C. Kapelios, 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

An Adult Patient with Early Pre-B Acute Lymphoblastic Leukemia with t(12;17)(p13;q21)/ZNF384-TAF15

F. Micci, N. Viniou, P. Diamantopoulos, 2018, In Vivo.

Bone marrow ribonucleotide reductase mRNA levels and methylation status as prognostic factors in patients with myelodysplastic syndrome treated with 5-Azacytidine

K. Zoi, A. Symeonidis, I. Kotsianidis, 2021, Leukemia & lymphoma.

Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study

A. Hatzakis, M. Psichogiou, V. Pappa, 2022, Therapeutic advances in hematology.

Prognosis and Management of BRAF V600E-Mutated Pregnancy-Associated Melanoma.

J. Kirkwood, H. Gogas, A. Stratigos, 2020, The oncologist.

Clinical course of COVID-19 infection in a melanoma patient treated with nivolumab and bempegaldesleukin: a case report

H. Gogas, P. Diamantopoulos, Amalia Anastasopoulou, 2022, Immunotherapy.

Diagnosis and treatment complications of primary cardiac lymphoma in an immunocompetent 28-year old man: a case report

S. Adamopoulos, P. Korkolopoulou, P. Foukas, 2019, BMC Cancer.

Concomitant development of neurologic and cardiac immune-related adverse effects in patients treated with immune checkpoint inhibitors for melanoma

H. Gogas, P. Diamantopoulos, Amalia Anastasopoulou, 2020, Melanoma research.

The genetics of myelodysplastic syndromes and the opportunities for tailored treatments

N. Viniou, P. Diamantopoulos, Konstantinos Kalopisis, 2022, Frontiers in Oncology.

Effectiveness of 5-Azacytidine in older patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia: A retrospective analysis of the Hellenic (Greek) MDS Study Group.

S. Papageorgiou, E. Hatzimichael, P. Repousis, 2019, Journal of geriatric oncology.

The outcome of patients with high‐risk MDS achieving stable disease after treatment with 5‐azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group

S. Papageorgiou, E. Hatzimichael, P. Repousis, 2018, Hematological oncology.

Leukemic transformation in patients with myelodysplastic syndromes after treatment with granulocyte colony-stimulating factor

G. Pangalis, S. Sachanas, X. Yiakoumis, 2012, Leukemia & lymphoma.

Expression, prognostic significance and mutational analysis of protein tyrosine phosphatase SHP-1 in chronic myeloid leukemia

M. Angelopoulou, I. Kotsianidis, M. Roumelioti, 2016, Leukemia & lymphoma.

An Adult Patient with Systemic Mastocytosis and B-Acute Lymphoblastic Leukemia

P. Korkolopoulou, E. Patsouris, G. Levidou, 2014, Case reports in medicine.

Survivin messenger RNA levels in Epstein-Barr virus-positive patients with leukemic low-grade B-cell lymphomas expressing the latent membrane protein 1: evidence of apoptotic function?

M. Angelopoulou, G. Pangalis, E. Terpos, 2014, Clinical lymphoma, myeloma & leukemia.

Bullous Pemphigoid-like Skin Lesions and Overt Eosinophilia in a Patient With Melanoma Treated With Nivolumab: Case Report and Review of the Literature.

H. Gogas, A. Stratigos, P. Diamantopoulos, 2018, Journal of immunotherapy.

Multichamber Involvement of Metastatic Cardiac Melanoma

H. Gogas, J. Barbetseas, C. Kapelios, 2022, Diagnostics.

Evaluation of the performance of tuberculin skin test and Quantiferon-TB gold in tube test in patients with hematologic malignancies

M. Kyrtsonis, G. Tsilimidos, A. Aessopos, 2017, Infectious diseases.

Late-onset nivolumab-mediated pneumonitis in a patient with melanoma and multiple immune-related adverse events.

H. Gogas, E. Kassi, P. Diamantopoulos, 2017, Melanoma research.

Rituximab in the treatment of EBV-positive low grade B-cell lymphoma.

M. Angelopoulou, G. Pangalis, M. Kyrtsonis, 2013, Anticancer research.

Post-Myelofibrosis Acute Myeloid Leukemia Effectively Treated with a Combination of Ruxolitinib and 5-Azacytidine

N. Viniou, P. Diamantopoulos, Nefeli Giannakopoulou, 2019, Oncology Research and Treatment.

Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder

Saira S Ahmed, P. Dhillon, P. Diamantopoulos, 2022, Cancers.

Are We Identifying Malnutrition in Hospitalized Patients with Hematologic Malignancies? Results from a Quality Clinical Audit

K. Poulia, D. Politis, N. Viniou, 2022, Diseases.

Isolated skeletal muscle recurrence of an originally nodal diffuse large B cell lymphoma

N. Viniou, P. Diamantopoulos, E. Variami, 2018, Medicine.

Acute Lymphoblastic Leukemia and Invasive Mold Infections: A Challenging Field

P. Diamantopoulos, Amalia Anastasopoulou, Christos Stafylidis, 2022, Journal of fungi.

Inflammatory Myopathy and Axonal Neuropathy in a Patient With Melanoma Following Pembrolizumab Treatment.

H. Gogas, P. Diamantopoulos, Amalia Anastasopoulou, 2017, Journal of immunotherapy.

Antiretroviral activity of 5-azacytidine during treatment of a HTLV-1 positive myelodysplastic syndrome with autoimmune manifestations

G. Vayopoulos, N. Viniou, John Meletis, 2012, Virology Journal.

Melanuria in a patient with BRAF-mutant metastatic melanoma of unknown primary: Insights on the pathophysiology, differential diagnosis, prognosis, and treatment.

H. Gogas, P. Diamantopoulos, Emmanouil Charakopoulos, 2022, The American journal of the medical sciences.

Melanoma immunotherapy dominates the field.

H. Gogas, P. Diamantopoulos, 2016, Annals of translational medicine.

Reconsidering the management of patients with cancer with viral hepatitis in the era of immunotherapy

E. Cholongitas, H. Gogas, J. Haanen, 2020, Journal for ImmunoTherapy of Cancer.

New primary melanoma in a patient under triple therapy with vemurafenib, cobimetinib, and atezolizumab for metastatic melanoma.

H. Gogas, E. Lakiotaki, P. Diamantopoulos, 2020, Melanoma research.

Significance of survivin mRNA blood levels in patients with melanoma.

H. Gogas, G. Papaxoinis, P. Diamantopoulos, 2018, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Translocation t(12;13)(p13;q14) in a patient with imatinib-sensitive MDS/MPD associated with resistance to treatment: review of the literature

A. Athanasiadou, P. Panagiotidis, A. Aessopos, 2011, Anti-cancer drugs.

Non-melanoma Skin Cancer and Cutaneous Melanoma from the Oncological Point of View

H. Gogas, A. Polyzos, P. Diamantopoulos, 2020 .

JAK2V617F positive polycythemia vera with paroxysmal nocturnal hemoglobinuria and visceral thromboses: a case report and review of the literature

S. Sakellariou, E. Gavriilaki, G. Dryllis, 2021, Thrombosis Journal.

PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome

D. Tiblalexi, N. Viniou, P. Diamantopoulos, 2021, Blood advances.

Advances in anticoagulation management of patients undergoing cardioversion of nonvalvular atrial fibrillation

K. Toutouzas, J. Barbetseas, G. Benetos, 2017, Hämostaseologie.

When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case report

P. Ascierto, E. Cholongitas, H. Gogas, 2020, Journal for ImmunoTherapy of Cancer.

First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis

D. Schadendorf, B. Schilling, A. Gesierich, 2019, Cancer Immunology, Immunotherapy.

H. Gogas, E. Kassi, G. Papaxoinis, 2019, Cancer medicine.

A Unique Case of Primary Extranodal Marginal Zone Lymphoma of the Anal Canal

K. Konstantopoulos, P. Korkolopoulou, M. Angelopoulou, 2019, Acta Haematologica.

Clinical considerations about the coexistence of melanoma and chronic lymphocytic leukemia in the era of targeted therapies, triggered by rare clinical scenarios. A case series and review of the literature

H. Gogas, D. Ziogas, N. Viniou, 2020, Therapeutic advances in medical oncology.

The Clinical and Prognostic Significance of Ribonucleotide Reductase Subunits RRM1 and RRM2 mRNA Levels in Patients with Chronic Lymphocytic Leukemia

M. Kyrtsonis, G. Dryllis, N. Viniou, 2023, Clinical Hematology International.

Prognostic significance of distant metastasis-free interval in patients with relapsed melanoma treated with BRAF with or without MEK inhibitors.

H. Gogas, H. Linardou, D. Bafaloukos, 2019, Melanoma research.

Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Melanoma Treated with Immunotherapy

H. Gogas, G. Magiorkinis, E. Solomou, 2022, Cancers.

Atypical Chronic Myelogenous Leukemia, BCR-ABL1 Negative: Diagnostic Criteria and Treatment Approaches

N. Viniou, P. Diamantopoulos, 2021, Frontiers in Oncology.

A case report of a fulminant Aeromonas hydrophila soft tissue infection in a patient with acute lymphoblastic leukemia harboring a rare translocation

M. Psichogiou, N. Viniou, P. Diamantopoulos, 2022, Current medical research and opinion.

Immunogenicity of a third dose of the BNT162b2 COVID-19 vaccine in patients with CLL: effects on treatment selection

A. Hatzakis, V. Pappa, M. Psichogiou, 2022, Annals of Hematology.

Remote Video-to-Video Eye Telemonitoring Use Case for Glaucoma Patients

Nancy Alonistioti, Ioannis P. Chochliouros, Eleni Patouni, 2014, AIAI Workshops.

Prognostic significance of signal transducer and activator of transcription 5 and 5b expression in Epstein–Barr virus‐positive patients with chronic lymphocytic leukemia

M. Angelopoulou, M. Kyrtsonis, V. Papadopoulou, 2016, Cancer medicine.

Tumor Protein 53 Gene Mutations Without 17p13 Deletion Have No Significant Clinical Implications in Chronic Lymphocytic Leukemia. Detection of a New Mutation.

P. Korkolopoulou, M. Angelopoulou, P. Kollia, 2017, Anticancer research.

Deregulation of Autophagy and Apoptosis in Patients with Myelodysplastic Syndromes: Implications for Disease Development and Progression

P. Kollia, I. Papassideri, A. Agathangelidis, 2023, Current issues in molecular biology.

Challenges in the treatment of melanoma with BRAF and MEK inhibitors in patients with sickle cell disease: case report and review of the literature

H. Gogas, M. Dimopoulou, P. Diamantopoulos, 2023, Therapeutic advances in hematology.

Bacillus Cereus in Hematological Malignancies

N. Viniou, P. Diamantopoulos, Amalia Anastasopoulou, 2022, Mediterranean journal of hematology and infectious diseases.

Myelodysplastic neoplasm with isolated thrombocytopenia and immune thrombocytopenic purpura in adults: insights from a comparison of two national registries

F. Kontopidou, S. Papageorgiou, V. Pappa, 2023, Leukemia.

The diagnosis and management of sarcoid-like reactions in patients with melanoma treated with BRAF and MEK inhibitors. A case series and review of the literature

H. Gogas, D. Ziogas, G. Liapis, 2021, Therapeutic advances in medical oncology.

Cytomegalovirus Infections in Patients Treated With Immune Checkpoint Inhibitors for Solid Malignancies

H. Gogas, J. Haanen, D. Ziogas, 2023, Open forum infectious diseases.

Ichthyosis associated with immune checkpoint blockade therapy: A novel cutaneous immune-related toxicity.

Z. Apalla, E. Lazaridou, C. Papageorgiou, 2022, European journal of cancer.

Evidence for regulation of oxidative stress by latent membrane protein 1 oncoprotein in patients with low-grade leukemic B cell lymphoma with latent Epstein–Barr virus infection

G. Pangalis, P. Kollia, G. Vaiopoulos, 2014, Leukemia & lymphoma.

Evidence that platelets from transfusion-dependent β-thalassemia patients induce T cell activation.

I. Papassotiriou, E. Solomou, A. Kattamis, 2022, Clinical immunology.

Staphylococcus aureus meningitis in a patient with mantle cell lymphoma under treatment with ibrutinib

G. Daikos, M. Psichogiou, N. Viniou, 2017, Annals of Hematology.

Lack of Association of Human Herpesvirus 6 (hHV-6) with Chronic Lymphocytic Leukemia and Leukemic Low-Grade B-Cell Lymphomas

M. Angelopoulou, T. Vassilakopoulos, N. Viniou, 2018 .

A Patient with Synchronous Gallbladder and Bone Plasmacytoma

P. Korkolopoulou, N. Viniou, E. Lakiotaki, 2023, Diagnostics.

An unusual case report of unilateral parotid gland sarcoidosis with spontaneous remission

N. Viniou, P. Diamantopoulos, Emmanouil Charakopoulos, 2019, Medicine.

A case report of a very late response to 5-azacytidine in a patient with lower risk myelodysplastic syndrome

N. Viniou, P. Diamantopoulos, Nefeli Giannakopoulou, 2018, Medicine.

First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis

D. Schadendorf, B. Schilling, A. Gesierich, 2019, Cancer Immunology, Immunotherapy.

Real world data on the prognostic significance of monocytopenia in myelodysplastic syndrome

S. Papageorgiou, V. Pappa, E. Hatzimichael, 2022, Scientific Reports.

S. Papageorgiou, A. Spathis, A. Symeonidis, 2021, Hematological Oncology.

The Role of Methylation in Chronic Lymphocytic Leukemia and Its Prognostic and Therapeutic Impacts in the Disease: A Systematic Review

M. Kyrtsonis, M. Dimou, P. Panayiotidis, 2024, Advances in Hematology.

Bone Marrow Iron Stores Are Not Associated with Increased Risk for Invasive Fungal Infections in Patients with Newly Diagnosed Acute Leukemia or Myelodysplastic Syndrome in Transformation: Is There a Relationship?

N. Sipsas, M. Voulgarelis, D. Kofteridis, 2023, Journal of fungi.

Prognostic Impact of Serum β2-Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 Patients

M. Angelopoulou, F. Kontopidou, G. Pangalis, 2024, Cancers.